Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response.
Gastroenterol Hepatol. 2008 Aug-Sep;31(7):421-6. doi: 10.1157/13125587.
Gastroenterol Hepatol. 2008.
PMID: 18783686
Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response.
Gonzalez-Lama Y, Fernandez-Blanco I, Lopez-SanRoman A, Taxonera C, Casis B, Tabernero S, Bermejo F, Martinez-Silva F, Mendoza JL, Martinez-Montiel P, Carneros JA, Sanchez F, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid.
Gonzalez-Lama Y, et al. Among authors: martinez silva f.
Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1609-14.
Hepatogastroenterology. 2008.
PMID: 19102352
Item in Clipboard
Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability.
Domènech E, Zabana Y, Garcia-Planella E, López San Román A, Nos P, Ginard D, Gordillo J, Martínez-Silva F, Beltrán B, Mañosa M, Cabré E, Gassull MA.
Domènech E, et al. Among authors: martinez silva f.
Aliment Pharmacol Ther. 2010 Jan 15;31(2):233-9. doi: 10.1111/j.1365-2036.2009.04170.x. Epub 2009 Oct 13.
Aliment Pharmacol Ther. 2010.
PMID: 19832727
Free article.
Item in Clipboard
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group.
Vermeire S, et al.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798037
Clinical Trial.
Item in Clipboard
Latin America consensus statement inflammatory bowel disease: importance of timely access to diagnosis and treatment.
Steinwurz F, Machado MB, Veitia G, De Paula JA, Bautista Martinez S, Vergara BI, Capdevielle B, Martinez Silva FA, Ramirez AL.
Steinwurz F, et al. Among authors: martinez silva fa.
Therap Adv Gastroenterol. 2023 Dec 23;16:17562848231207312. doi: 10.1177/17562848231207312. eCollection 2023.
Therap Adv Gastroenterol. 2023.
PMID: 38144423
Free PMC article.
Item in Clipboard
Cite
Cite